Harte Hanks, Inc. (HHS) News
Track canonical SquawkNews coverage tagged to HHS, Harte Hanks, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Premarket gainers list led by GXAI, CURI and IVDA
A premarket movers list shows GXAI, CURI, IVDA, HLIT, OMER, FGI, BIVI, FRGT, ONDG and HHS among the top percentage gainers, with no catalyst supplied.
EQUITY | Aug 13, 2026, 09:43 AM UTC
L
AKTS PBLS HIMS Today and tomorrow, an FDA advisory committee will mull whether compounding pharmacies should be allowed to manufacture seven
AKTS PBLS HIMS Today and tomorrow, an FDA advisory committee will mull whether compounding pharmacies should be allowed to manufacture seven peptides, in particular. This could mean a clash between career FDA scientists,
REGULATION | Jul 23, 2026, 12:13 PM UTC
L
NEO - Neogenomics Reveals Settlement Of Voluntary Disclosure To OIG-HHS; Co To Pay $9,813,260 Plus Interest At A Rate Of 4.250% Per Annum Fr
NEO - Neogenomics Reveals Settlement Of Voluntary Disclosure To OIG-HHS; Co To Pay $9,813,260 Plus Interest At A Rate Of 4.250% Per Annum From January 16, 2026 To Resolve The Matter
EQUITY | Jul 20, 2026, 09:32 PM UTC